Potential of Manipulating the Dialysate Temperature for Prevention of Intra-dialytic Hypotensive Episodes in Maintenance Hemodialysis Patients View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2013-2015

ABSTRACT

Hemodialysis (HD) is widely used treatment for end stage renal diseases (ESRD) patients. The chief aims of HD are solute and fluid removal. Decades of practice have improved HD care, but more can be done to improve morbidity and mortality. Enhancing toxin removal is an important consideration for improved patient outcomes. Also, decreasing the incidence of intra-dialytic hypotensive (IDH) episodes (dominant in Singapore patient cohort) can significantly reduce associated morbidities and mortality. A simple maneuver for clinicians is the dialysate temperature. Literature suggests that a lower dialysate temperature (35ºC) results in reduced hypotensive episodes by vasoconstriction. Conversely, higher dialysate temperature resulting in higher blood temperature decreases the peripheral resistance, leading to increased toxin removal, but may cause IDH episodes partly due to vasodilation. Optimal manipulation of the dialysate temperature is therefore primary handles to obtain the improved patient outcomes. In this study, the effect of dialysate temperature (cool vs. warm dialysate) on toxin removal will be studied. In both the interventions, outcome measure will be patient hemodynamic response and amount of toxins removed. The spent dialysate will be collected to study the quantum of toxin removed. Detailed Description Cool dialysate, by vasoconstriction, is simple maneuver to control and/or prevent incidence of intra-dialytic hypotension (IDH). During dialysis fluid is continuously removed. IDH occurs when plasma refilling rate is smaller than the set ultra-filtration rate. When plasma refiling rate is small, continuous fluid removal bring patient to the threshold state where patient does not have sufficient fluid in central compartment. This leads to the cascade of events, viz., low blood pressure, muscle cramps, dizziness, being first few manifestation. To minimize the occurrence of such events, clinicians often prescribe cool dialysate resulting in vasoconstriction, which ensures sufficient fluid volume in central body compartment so that continuous fluid loss does not impact patient hemodynamics severely. It is important to note that vasoconstriction may also inhibit the toxin movement from remote peripheral compartments to central blood compartment, and thus less toxin will be removed. On the other hand warm dialysate leading to vasodilation will mobilize the toxins in remote peripheral compartments and increase the toxin influx in central blood compartment. Few researchers have investigate the effect of dialysate temperature on urea removal, but urea is not a true marker of toxin milieu. In this pilot clinical research, we will compare the effect of dialysate temperature on removal of both small and large sized uremic toxins. Our objective is not to study the effect of dialysate temperature on incidence of IDH, so we will recruit subjects who are stable on dialysis and have no prior history of IDH episodes. More... »

URL

https://clinicaltrials.gov/show/NCT02064153

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Hemodialysis (HD) is widely used treatment for end stage renal diseases (ESRD) patients. The chief aims of HD are solute and fluid removal. Decades of practice have improved HD care, but more can be done to improve morbidity and mortality. Enhancing toxin removal is an important consideration for improved patient outcomes. Also, decreasing the incidence of intra-dialytic hypotensive (IDH) episodes (dominant in Singapore patient cohort) can significantly reduce associated morbidities and mortality. A simple maneuver for clinicians is the dialysate temperature. Literature suggests that a lower dialysate temperature (35\u00baC) results in reduced hypotensive episodes by vasoconstriction. Conversely, higher dialysate temperature resulting in higher blood temperature decreases the peripheral resistance, leading to increased toxin removal, but may cause IDH episodes partly due to vasodilation. Optimal manipulation of the dialysate temperature is therefore primary handles to obtain the improved patient outcomes. In this study, the effect of dialysate temperature (cool vs. warm dialysate) on toxin removal will be studied. In both the interventions, outcome measure will be patient hemodynamic response and amount of toxins removed. The spent dialysate will be collected to study the quantum of toxin removed.\n\nDetailed Description\nCool dialysate, by vasoconstriction, is simple maneuver to control and/or prevent incidence of intra-dialytic hypotension (IDH). During dialysis fluid is continuously removed. IDH occurs when plasma refilling rate is smaller than the set ultra-filtration rate. When plasma refiling rate is small, continuous fluid removal bring patient to the threshold state where patient does not have sufficient fluid in central compartment. This leads to the cascade of events, viz., low blood pressure, muscle cramps, dizziness, being first few manifestation. To minimize the occurrence of such events, clinicians often prescribe cool dialysate resulting in vasoconstriction, which ensures sufficient fluid volume in central body compartment so that continuous fluid loss does not impact patient hemodynamics severely. It is important to note that vasoconstriction may also inhibit the toxin movement from remote peripheral compartments to central blood compartment, and thus less toxin will be removed. On the other hand warm dialysate leading to vasodilation will mobilize the toxins in remote peripheral compartments and increase the toxin influx in central blood compartment. Few researchers have investigate the effect of dialysate temperature on urea removal, but urea is not a true marker of toxin milieu. In this pilot clinical research, we will compare the effect of dialysate temperature on removal of both small and large sized uremic toxins. Our objective is not to study the effect of dialysate temperature on incidence of IDH, so we will recruit subjects who are stable on dialysis and have no prior history of IDH episodes.", 
    "endDate": "2015-01-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT02064153", 
    "keywords": [
      "temperature", 
      "prevention", 
      "hemodialysis patient", 
      "Renal Dialysis", 
      "HD", 
      "used treatment", 
      "Chronic Kidney Failure", 
      "patient", 
      "solute", 
      "removal", 
      "practice", 
      "care", 
      "morbidity", 
      "mortality", 
      "Enhancing", 
      "important consideration", 
      "improved patient outcome", 
      "incidence", 
      "IDH", 
      "episode", 
      "patient cohort", 
      "associated morbidity", 
      "maneuver", 
      "clinician", 
      "vasoconstriction", 
      "Vascular Resistance", 
      "vasodilation", 
      "manipulation", 
      "dialysate", 
      "intervention", 
      "Outcome Assessment", 
      "hemodynamic response", 
      "toxin", 
      "quantum", 
      "cool", 
      "control", 
      "hypotension", 
      "dialysis", 
      "refilling", 
      "filtration rate", 
      "plasma", 
      "threshold", 
      "fluid", 
      "compartment", 
      "cascade", 
      "viz.", 
      "Muscle Cramp", 
      "dizziness", 
      "manifestation", 
      "occurrence", 
      "fluid volume", 
      "body compartment", 
      "fluid loss", 
      "impact patient", 
      "note", 
      "movement", 
      "influx", 
      "urea", 
      "marker", 
      "milieu", 
      "Research", 
      "uremic toxin", 
      "prior history"
    ], 
    "name": "Potential of Manipulating the Dialysate Temperature for Prevention of Intra-dialytic Hypotensive Episodes in Maintenance Hemodialysis Patients", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT02064153"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00016.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.412106.0", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.4280.e", 
        "type": "Organization"
      }
    ], 
    "startDate": "2013-07-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/s12882-015-0017-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043798785", 
          "https://doi.org/10.1186/s12882-015-0017-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12882-015-0017-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043798785", 
          "https://doi.org/10.1186/s12882-015-0017-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083265088", 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT02064153"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT02064153'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT02064153'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT02064153'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT02064153'


 

This table displays all metadata directly associated to this object as RDF triples.

90 TRIPLES      16 PREDICATES      81 URIs      72 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT02064153 schema:about anzsrc-for:3053
2 schema:description Hemodialysis (HD) is widely used treatment for end stage renal diseases (ESRD) patients. The chief aims of HD are solute and fluid removal. Decades of practice have improved HD care, but more can be done to improve morbidity and mortality. Enhancing toxin removal is an important consideration for improved patient outcomes. Also, decreasing the incidence of intra-dialytic hypotensive (IDH) episodes (dominant in Singapore patient cohort) can significantly reduce associated morbidities and mortality. A simple maneuver for clinicians is the dialysate temperature. Literature suggests that a lower dialysate temperature (35ºC) results in reduced hypotensive episodes by vasoconstriction. Conversely, higher dialysate temperature resulting in higher blood temperature decreases the peripheral resistance, leading to increased toxin removal, but may cause IDH episodes partly due to vasodilation. Optimal manipulation of the dialysate temperature is therefore primary handles to obtain the improved patient outcomes. In this study, the effect of dialysate temperature (cool vs. warm dialysate) on toxin removal will be studied. In both the interventions, outcome measure will be patient hemodynamic response and amount of toxins removed. The spent dialysate will be collected to study the quantum of toxin removed. Detailed Description Cool dialysate, by vasoconstriction, is simple maneuver to control and/or prevent incidence of intra-dialytic hypotension (IDH). During dialysis fluid is continuously removed. IDH occurs when plasma refilling rate is smaller than the set ultra-filtration rate. When plasma refiling rate is small, continuous fluid removal bring patient to the threshold state where patient does not have sufficient fluid in central compartment. This leads to the cascade of events, viz., low blood pressure, muscle cramps, dizziness, being first few manifestation. To minimize the occurrence of such events, clinicians often prescribe cool dialysate resulting in vasoconstriction, which ensures sufficient fluid volume in central body compartment so that continuous fluid loss does not impact patient hemodynamics severely. It is important to note that vasoconstriction may also inhibit the toxin movement from remote peripheral compartments to central blood compartment, and thus less toxin will be removed. On the other hand warm dialysate leading to vasodilation will mobilize the toxins in remote peripheral compartments and increase the toxin influx in central blood compartment. Few researchers have investigate the effect of dialysate temperature on urea removal, but urea is not a true marker of toxin milieu. In this pilot clinical research, we will compare the effect of dialysate temperature on removal of both small and large sized uremic toxins. Our objective is not to study the effect of dialysate temperature on incidence of IDH, so we will recruit subjects who are stable on dialysis and have no prior history of IDH episodes.
3 schema:endDate 2015-01-01T00:00:00Z
4 schema:keywords Chronic Kidney Failure
5 Enhancing
6 HD
7 IDH
8 Muscle Cramp
9 Outcome Assessment
10 Renal Dialysis
11 Research
12 Vascular Resistance
13 associated morbidity
14 body compartment
15 care
16 cascade
17 clinician
18 compartment
19 control
20 cool
21 dialysate
22 dialysis
23 dizziness
24 episode
25 filtration rate
26 fluid
27 fluid loss
28 fluid volume
29 hemodialysis patient
30 hemodynamic response
31 hypotension
32 impact patient
33 important consideration
34 improved patient outcome
35 incidence
36 influx
37 intervention
38 maneuver
39 manifestation
40 manipulation
41 marker
42 milieu
43 morbidity
44 mortality
45 movement
46 note
47 occurrence
48 patient
49 patient cohort
50 plasma
51 practice
52 prevention
53 prior history
54 quantum
55 refilling
56 removal
57 solute
58 temperature
59 threshold
60 toxin
61 urea
62 uremic toxin
63 used treatment
64 vasoconstriction
65 vasodilation
66 viz.
67 schema:name Potential of Manipulating the Dialysate Temperature for Prevention of Intra-dialytic Hypotensive Episodes in Maintenance Hemodialysis Patients
68 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT02064153
69 schema:sdDatePublished 2019-03-07T15:25
70 schema:sdLicense https://scigraph.springernature.com/explorer/license/
71 schema:sdPublisher N1a499946edef45fd8ed0a814a2c119d0
72 schema:sponsor https://www.grid.ac/institutes/grid.412106.0
73 https://www.grid.ac/institutes/grid.4280.e
74 schema:startDate 2013-07-01T00:00:00Z
75 schema:subjectOf sg:pub.10.1186/s12882-015-0017-5
76 https://app.dimensions.ai/details/publication/pub.1083265088
77 schema:url https://clinicaltrials.gov/show/NCT02064153
78 sgo:license sg:explorer/license/
79 sgo:sdDataset clinical_trials
80 rdf:type schema:MedicalStudy
81 N1a499946edef45fd8ed0a814a2c119d0 schema:name Springer Nature - SN SciGraph project
82 rdf:type schema:Organization
83 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
84 rdf:type schema:DefinedTerm
85 sg:pub.10.1186/s12882-015-0017-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043798785
86 https://doi.org/10.1186/s12882-015-0017-5
87 rdf:type schema:CreativeWork
88 https://app.dimensions.ai/details/publication/pub.1083265088 schema:CreativeWork
89 https://www.grid.ac/institutes/grid.412106.0 schema:Organization
90 https://www.grid.ac/institutes/grid.4280.e schema:Organization
 




Preview window. Press ESC to close (or click here)


...